GeneOne Life Science, Inc.

Clinical trials sponsored by GeneOne Life Science, Inc., explained in plain language.

GeneOne Life Science, Inc. 011000 KRX

A biopharmaceutical company developing DNA vaccines and immunotherapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Completed 1

DNA vaccine against COVID-19 shows promise in early trial

Vaccine Completed

This study tested a new DNA vaccine called GLS-5310 for COVID-19 in 171 healthy adults aged 19 to 85. The vaccine is given as a shot under the skin and aims to teach the body to fight the virus. Researchers checked for side effects and measured immune responses like T cells and a…

Phase 1/2 • Sponsor: GeneOne Life Science, Inc. • Aim: Vaccine

Last updated Jun 26, 2026 12:56 UTC

GeneOne Life Science, Inc.

DNA vaccine against COVID-19 shows promise in early trial